Abstract
Although thyroid gland function is mainly under the control of pituitary TSH, other factors may also play a role in this process. Iodine is not used only by the thyroid to synthesize thyroid hormones but also directly influences a number of parameters such as thyroid proliferation and function. Thyroid autoregulation has been related to intraglandular content of an unknown putative iodocompound. The thyroid is capable of producing different iodolipids such as 6-iododeltalactone (ILδ) and 2-iodohexadecanal (2-IHDA). Data from different laboratories have shown that these iodolipids can inhibit several thyroid parameters suggesting that these compounds may be the intermediates in the thyroid autoregulation process.
Keywords: Iodine, iodocompounds, iodohexadecanal, iodolactone, iodolipids, thyroid, Thyroid NADPH oxidases, Metilmercaptoimidazol, Phosphatidyl inositol, Propylthiouracil, Urokinase-type plasminogen activator
Current Chemical Biology
Title: Thyroid: Iodine Beyond the Thyronines
Volume: 5 Issue: 3
Author(s): Guillermo J. Juvenal, Lisa Thomasz, Romina Oglio, Marina Perona, Mario A. Pisarev, Luiciano Rossich and Leonardo Salvarredi
Affiliation:
Keywords: Iodine, iodocompounds, iodohexadecanal, iodolactone, iodolipids, thyroid, Thyroid NADPH oxidases, Metilmercaptoimidazol, Phosphatidyl inositol, Propylthiouracil, Urokinase-type plasminogen activator
Abstract: Although thyroid gland function is mainly under the control of pituitary TSH, other factors may also play a role in this process. Iodine is not used only by the thyroid to synthesize thyroid hormones but also directly influences a number of parameters such as thyroid proliferation and function. Thyroid autoregulation has been related to intraglandular content of an unknown putative iodocompound. The thyroid is capable of producing different iodolipids such as 6-iododeltalactone (ILδ) and 2-iodohexadecanal (2-IHDA). Data from different laboratories have shown that these iodolipids can inhibit several thyroid parameters suggesting that these compounds may be the intermediates in the thyroid autoregulation process.
Export Options
About this article
Cite this article as:
J. Juvenal Guillermo, Thomasz Lisa, Oglio Romina, Perona Marina, A. Pisarev Mario, Rossich Luiciano and Salvarredi Leonardo, Thyroid: Iodine Beyond the Thyronines, Current Chemical Biology 2011; 5 (3) . https://dx.doi.org/10.2174/2212796811105030163
DOI https://dx.doi.org/10.2174/2212796811105030163 |
Print ISSN 2212-7968 |
Publisher Name Bentham Science Publisher |
Online ISSN 1872-3136 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Obesity: Current Treatment and Future Horizons
Mini-Reviews in Medicinal Chemistry Chronobiology of the Neuroimmunoendocrine System and Aging
Current Pharmaceutical Design Targeting the PI3K/Akt/mTOR Axis by Apigenin for Cancer Prevention
Anti-Cancer Agents in Medicinal Chemistry MicroRNAs: A Critical Regulator and a Promising Therapeutic and Diagnostic Molecule for Diabetic Cardiomyopathy
Current Gene Therapy Retroviral Gene Therapy: Safety Issues and Possible Solutions
Current Gene Therapy Tyrosine Kinases as Molecular Targets to Inhibit Cancer Progression and Metastasis
Current Pharmaceutical Design Peptidic Tumor Targeting Agents: The Road from Phage Display Peptide Selections to Clinical Applications
Current Pharmaceutical Design Antioxidant Effect of Mangiferin and its Potential to be a Cancer Chemoprevention Agent
Letters in Drug Design & Discovery The Diagnosis of Large Airway Pathology and the Role of Rigid Bronchoscopy
Current Respiratory Medicine Reviews The Impact of IL-17 in Atherosclerosis
Current Medicinal Chemistry The Role of Tumor Associated Macrophages (TAMs) in Cancer Progression, Chemoresistance, Angiogenesis and Metastasis - Current Status
Current Medicinal Chemistry Novel and Emerging Drugs for Rarer Chronic Lymphoid Leukaemias
Current Cancer Drug Targets The Applications of Targeting Anti-Cancer Agents in Cancer Therapeutics
Anti-Cancer Agents in Medicinal Chemistry Fibroblast Activation Protein in Remodeling Tissues
Current Molecular Medicine MicroRNAs in Cancer Therapy: From Bench to Bedside
Current Cancer Therapy Reviews Nilotinib, A Tyrosine Kinase Inhibitor, Suppresses the Cell Growth and Triggers Autophagy in Papillary Thyroid Cancer
Anti-Cancer Agents in Medicinal Chemistry Nuclear Receptors CAR and PXR in Metabolism and Elimination of Drugs
Current Pharmacogenomics SENP1 as A Biomarker for the Diagnosis of Cancer: Review of the Science and Published Patents
Recent Patents on Biomarkers Insect Peptides – Perspectives in Human Diseases Treatment
Current Medicinal Chemistry Radionuclide Therapy of Cancer with Radiolabeled Antibodies
Anti-Cancer Agents in Medicinal Chemistry